Mainz Biomed B.V.
MYNZ | NASDAQ
$3.59
$0.00 (0.00%)
Nov 2, 2026, 9:57 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | 250.36K | 286.72K | 373.22K | 520.77K | 214.76K | 500.21K | 251.4K | 278.48K | 160.04K | 417.31K |
Cost of Revenue | n/a | 165.95K | 597.06K | 117.37K | 201.74K | 163.49K | 222.33K | 217.99K | 129.74K | 334.95K | 64.77K |
Gross Profit | n/a | 84.41K | -310.34K | 255.85K | 319.04K | 40.25K | 277.88K | 33.41K | 148.74K | -174.92K | 352.54K |
Operating Income | -9.89M | -5.41M | -8.09M | -8.89M | -9.81M | -12.23M | -12.98M | -12.28M | -13.9M | -9.47M | -240.75K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 231.83K | 170.12K | 169.05K |
Pretax Income | -10.07M | -7.87M | -8.34M | -10.63M | -11.02M | -5.18M | -13.12M | -12.51M | -13.88M | -11.43M | -240.75K |
Net Income | -11.02M | -7.87M | -8.34M | -10.63M | -11.02M | -5.18M | -13.27M | -12.58M | -13.88M | -11.43M | -240.75K |
Selling & General & Admin | 5.34M | 2.4M | 5.01M | 5.89M | 6.88M | 8.6M | 7.94M | 9.47M | 13.34M | 9.03M | 240.75K |
Research & Development | 294.57K | 2.14M | 2.77M | 2.6M | 3.24M | 3.85M | 5.25M | 2.96M | 696.29K | 260.54K | 206.15K |
Other Expenses | 4.26M | 950.41K | -1 | 656.34K | n/a | 1.45M | 62.74K | 220.63K | n/a | 10.75K | 10.75K |
Operating Expenses | 9.89M | 5.49M | 7.78M | 9.14M | 10.13M | 13.9M | 13.25M | 12.45M | 13.91M | 11.08M | 240.75K |
Interest Expense | -7.21K | -15.18K | 215.26K | 1.08M | 659.47K | 662.86K | 146.72K | 289.32K | n/a | 84.79K | 84.79K |
Selling & Marketing Expenses | 1.46M | 281.9K | 2.35M | 2.33M | 2.36M | 1.25M | 3.12M | 2.1M | 2.88M | 807.19K | 150.34K |
Cost & Expenses | n/a | 5.66M | 8.38M | 9.26M | 10.33M | 14.06M | 13.48M | 12.67M | 14.04M | 11.42M | 240.75K |
Income Tax Expense | 944.16K | n/a | n/a | n/a | n/a | n/a | 146.72K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 17.85M | 6M | 3.14M | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 13.82M | 8.81M | 12.01M |
Shares Outstanding (Diluted) | 17.85M | 6M | 3.14M | 968.23K | 558.75K | 442.04K | 29.38M | 14.16M | 14.29M | 8.81M | 12.01M |
EPS (Basic) | -0.62 | -0.43 | -2.65 | -7.71 | -19.73 | -11.73 | -0.90 | -0.87 | -1 | -1.30 | -0.02 |
EPS (Diluted) | -0.62 | -0.43 | -2.65 | -7.71 | -19.73 | -11.73 | -0.90 | -0.89 | -0.98 | -1.30 | -0.02 |
EBITDA | -9.89M | -5.14M | -7.74M | -10.09M | -9.47M | -12.61M | -12.4M | -11.88M | -13.84M | -9.43M | -219.8K |
EBIT | n/a | -5.41M | -8.09M | -10.77M | -9.81M | -13.07M | -12.98M | -12.2M | -13.9M | -9.47M | -254.63K |
Depreciation & Amortization | n/a | 267.86K | 347.86K | 680.89K | 336.15K | 459.82K | 574.7K | 404.4K | 55.02K | 35.09K | 34.84K |
Add to Watchlist
Select watchlists to add or remove MYNZ